Trial
NCT03940690
Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Collaborators
—
Condition
Retinal Telangiectasis
Intervention
Anti-VEGF injections of bevacizumab
Why stopped
Study futility based on the interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-10